OwnershipPublicly listed · Nasdaq: STIMSEC EDGAR company record and tickers file (Nasdaq: STIM) · checked Oct 28, 2026
Commercial developmentNot yet assessedWe only state a stage once a source supports it. Having a product on sale does not show it works or makes money.
Investment accessVerified public listingListed as Nasdaq: STIM, per the SEC's company tickers file. A listing means shares trade publicly; it says nothing about whether they are a good investment.Source · checked Oct 28, 2026
Evidence is labelled on each development below (company-reported, regulatory filing or government record), not on the company as a whole. Next scheduled recheck: Nov 27, 2026.
7developments published
$828,890US federal obligations on record
6federal awards
Aug 11, 2026latest development
Timeline
- Aug 11, 2026 · Reported results
Neuronetics Reports Second Quarter 2026 Financial and Operating Results
Company-reported - Aug 11, 2026 · Leadership change
Neuronetics reports changes involving its directors or officers (Form 8-K, Item 5.02)
Regulatory filing - Jul 9, 2026 · Leadership change
Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes
Company-reported - Jun 16, 2026 · Leadership change
Neuronetics reports changes involving its directors or officers (Form 8-K, Item 5.02)
Regulatory filing - May 28, 2026 · Shareholder vote
Neuronetics reports results of a shareholder vote (Form 8-K, Item 5.07)
Regulatory filing - May 18, 2026 · Leadership change
Neuronetics reports changes involving its directors or officers (Form 8-K, Item 5.02)
Regulatory filing - May 5, 2026 · Reported results
Neuronetics Reports First Quarter 2026 Financial and Operating Results
Company-reported
Profile
- Legal name
- Neuronetics, Inc.
- Listing
- Nasdaq STIM
- SEC filer
- CIK 0001227636 ↗
- SEC industry code
- Surgical & Medical Instruments & Apparatus
- Incorporated
- DE
- Coverage
- Filings + federal awards
Mix of developments
Watch Neuronetics
Anything new from Neuronetics lands in your digest, with the source beside it. Following is about information, never an investment action. Up to 10 companies or frontiers on Pro, $49/month.
Follow this companyPreview a sample digestUS federal awards
From USAspending.gov. Obligated is money the government has committed, not company revenue and not the contract’s potential ceiling. Outlays is what has actually been paid. Totals: $828,890 obligated, $126,560 paid out across 6 awards.
| Agency | Description | Obligated | Paid out | Period | Record |
|---|---|---|---|---|---|
| Department of the Army | NEW TMS TRANSCRANIAL MAGNETIC STIMULATION | $725,690 | $126,560 | May 20, 2021 – May 19, 2026 | USAspending ↗ |
| Department of Veterans Affairs | 644-NEURONETICS TRANSCRANIAL MAGNETIC STIMULATORS PREVENTATIVE MAINTENANCE | $44,000 | Not stated | Sep 1, 2021 – Aug 31, 2025 | USAspending ↗ |
| Department of Veterans Affairs | NEURONETICS NEUROSTAR TMS THERAPY SYSTEM | $19,600 | Not stated | Mar 22, 2023 – Mar 21, 2028 | USAspending ↗ |
| Defense Health Agency | THERAPEUTIC MAGNETIC SYSTEM ANNUAL MAINT MODEL # 81-00315-000 | $19,600 | $0.00 | May 1, 2022 – Apr 30, 2026 | USAspending ↗ |
| Defense Health Agency | TRANSCRANIAL MAGNETIC STIMULATION IS A PSYCHIATRIC PROCEDURE THAT STIMULATES AREAS OF THE BRAIN WITH A POWERFUL (1.5 TESLA) MAGNET. | $10,200 | Not stated | Sep 27, 2025 – Sep 26, 2026 | USAspending ↗ |
| Department of Veterans Affairs | HIGHLY SPECIALIZED HOSPITAL EQUIPMENT SERVICE AGREEMENT. | $9,800 | Not stated | Nov 2, 2022 – Nov 1, 2025 | USAspending ↗ |